O
ZTS icon

OrbiMed’s Zoetis ZTS Stock Holding History

OrbiMed’s Portfolio ZTS Stock Details ZTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-229,000
Closed -$7.39M – 145
2014
Q2 		$7.39M Buy
229,000
+8,000
+4% +$245K 0.09% 96
2014
Q1 		$6.4M Sell
221,000
-58,000
-21% -$1.77M 0.08% 111
2013
Q4 		$9.12M Buy
+279,000
New +$8.9M 0.13% 82
2013
Q3 		– Sell
-131,732
Closed -$4.07M – 135
2013
Q2 		$4.07M Buy
+131,732
New +$4.27M 0.09% 107

Other funds holding ZTS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

OrbiMed's ZTS Position: Q3 2014 in Review

OrbiMed sold out of Zoetis (ZTS) in Q3 2014, closing a stake of 229,000 shares — an estimated $7.39M sold.

OrbiMed first reported a position in ZTS in Q2 2013 and held it in 4 quarters. The position peaked at $9.12M in Q4 2013. 514 funds tracked by Wall St. Rank hold ZTS as of Q3 2014.

  • OrbiMed reported no remaining Zoetis position as of Q3 2014 after selling out during the quarter.
  • OrbiMed sold 229,000 Zoetis shares in Q3 2014, an estimated $7.39M.
  • OrbiMed first reported a position in Zoetis in Q2 2013 and held it in 4 quarters.
  • OrbiMed's Zoetis position peaked at $9.12M in Q4 2013.
  • 514 funds tracked by Wall St. Rank held Zoetis as of Q3 2014.

Based on OrbiMed's 13F filing for Q3 2014, filed 14 Nov 2014.